MedPath

Effect of rectal indomethacin and intravenous hydration in the prevention of pancreatitis after endoscopic retrograde cholangiopancreatography (single blind clinicaltrial)

Phase 3
Conditions
Calculus of bile duct without cholangitis or cholecystitis.
Choledocholithiasis
Registration Number
IRCT2014082418915N1
Lead Sponsor
Mashad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
406
Inclusion Criteria

Age>18y; Patients are eligible if they are diagnosed with choledocolithiasis. Exclusion criteria: Patients with previous unsuccessful sphincterotomy; Decreased state of consciousness; Cardiovascular, renal diseases and under dialysis patients; Increased risk of bleeding; Evident acute pancreatitis, chronic pancreatitis or pancreatic cancer; Hyperamylasemia (= 150 IU/L); Allergy or hypersensitivity to indomethacin or water-soluble contrast solutions; Having ingested NSAIDs a week earlier are enrol

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Frequency of post endoscopic retrograde cholangiopancreatography pancreatitis. Timepoint: 2,12,24 hours post endoscopic retrograde cholangiopancreatography. Method of measurement: Clinical exam and serum amylase measurement.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath